Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Adult Patients With Rheumatoid Arthritis (SVOBODA Programme) [Phase 4]

View source ↗

Summary

Phase 4 trial update for tocilizumab (RoActemra/Actemra) in adults with rheumatoid arthritis under the SVOBODA programme. The study is completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2014-09-25